Anonymous
Guest
Anonymous
Guest
After everything we've been through and gets even more money? Not to mention the others who have put in this situation. OMG I can't believe they get this money. For what?
KV Pharmaceutical CEO Divis’ pay more than doubled in fiscal 2012
St. Louis Business Journal by Greta Weiderman, Web Editor
Date: Thursday, July 26, 2012, 4:47pm CDT
KV Pharmaceutical Co. President and CEO Gregory Divis Jr. earned $976,270 in the fiscal year ended March 31.
KV Pharmaceutical Co. President and CEO Gregory Divis Jr. earned $976,270 in the fiscal year ended March 31, more than double the $385,102 he was paid in fiscal 2011, according to a proxy statement the company filed Thursday with the Securities and Exchange Commission.
His 2012 earnings were comprised of a $638,750 salary, a $130,000 bonus, $204,189 in option awards and $3,331 in other compensation, which includes a $2,909 car allowance, a 401(k) match and group term life insurance.
The total pay for other top executives was as follows:
Treasurer and Chief Financial Officer Thomas McHugh earned $506,615 in fiscal 2012, including a $65,000 bonus. Hit total comp in fiscal 2011 was $320,950.
Vice President, General Counsel and Secretary Patrick Christmas earned $530,604 in fiscal 2012. He joined the company in June 2011.
KV Pharmaceutical Co. officials said July 20 that the company has been notified by the New York Stock Exchange that it is below listing standard criteria due to the company’s average market capitalization being less than $50 million over a 30-day trading period and its stockholder’s equity being less than $50 million.
After years of missteps, mismanagement and mounting losses, KV Pharmaceutical’s ability to survive is in question. The company itself raised doubts as to its ability to continue as a going concern in its quarterly filing Feb. 9 with the Securities and Exchange Commission.
The Bridgeton-based drug maker reported a net loss of $102 million on revenue of $23 million for its fiscal year ended March 31. KV has scheduled its annual shareholders meeting for Sept. 13 at the Sheraton Plaza Tower Hotel in Westport Plaza
KV Pharmaceutical CEO Divis’ pay more than doubled in fiscal 2012
St. Louis Business Journal by Greta Weiderman, Web Editor
Date: Thursday, July 26, 2012, 4:47pm CDT
KV Pharmaceutical Co. President and CEO Gregory Divis Jr. earned $976,270 in the fiscal year ended March 31.
KV Pharmaceutical Co. President and CEO Gregory Divis Jr. earned $976,270 in the fiscal year ended March 31, more than double the $385,102 he was paid in fiscal 2011, according to a proxy statement the company filed Thursday with the Securities and Exchange Commission.
His 2012 earnings were comprised of a $638,750 salary, a $130,000 bonus, $204,189 in option awards and $3,331 in other compensation, which includes a $2,909 car allowance, a 401(k) match and group term life insurance.
The total pay for other top executives was as follows:
Treasurer and Chief Financial Officer Thomas McHugh earned $506,615 in fiscal 2012, including a $65,000 bonus. Hit total comp in fiscal 2011 was $320,950.
Vice President, General Counsel and Secretary Patrick Christmas earned $530,604 in fiscal 2012. He joined the company in June 2011.
KV Pharmaceutical Co. officials said July 20 that the company has been notified by the New York Stock Exchange that it is below listing standard criteria due to the company’s average market capitalization being less than $50 million over a 30-day trading period and its stockholder’s equity being less than $50 million.
After years of missteps, mismanagement and mounting losses, KV Pharmaceutical’s ability to survive is in question. The company itself raised doubts as to its ability to continue as a going concern in its quarterly filing Feb. 9 with the Securities and Exchange Commission.
The Bridgeton-based drug maker reported a net loss of $102 million on revenue of $23 million for its fiscal year ended March 31. KV has scheduled its annual shareholders meeting for Sept. 13 at the Sheraton Plaza Tower Hotel in Westport Plaza